Myriad Genetics (MYGN) Meets Q4 Earnings Estimates
Portfolio Pulse from
Myriad Genetics (MYGN) reported Q4 earnings of $0.03 per share, meeting the Zacks Consensus Estimate but down from $0.04 per share a year ago.
February 25, 2025 | 12:15 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Myriad Genetics reported Q4 earnings of $0.03 per share, meeting expectations but showing a decline from the previous year's $0.04 per share.
The earnings report met analyst expectations, which is neutral for the stock price. However, the decline from last year's earnings per share may concern some investors, balancing the impact.
CONFIDENCE 100
IMPORTANCE 70
RELEVANCE 100